Alan Wake 2 Passes 3 Million Sales and Begins Turning a Profit

Remedy Entertainment’s 2026 first-half financial report says Alan Wake 2 had topped 3 million copies sold by the second quarter of this year and has recovered its development costs. The original report was produced and published by GamerSky; unauthorized reproduction is prohibited.

For a horror sequel with a slow-burn sales curve, that number matters. Alan Wake 2 launched at the end of 2023 to strong media reviews, but it had to fight for oxygen beside Baldur’s Gate 3, one of the biggest games of that period. Horror is also a harder genre to sell to a broad audience. Reaching 3 million copies suggests Alan Wake 2 was not relying solely on launch-week momentum.

Horror games are rarely easy sells, even for players open to slower, moodier experiences. Their oppressive atmosphere can be a barrier, especially when a game asks for sustained attention rather than short sessions. Alan Wake 2’s gradual sales growth, however, suggests word of mouth has kept carrying it well beyond release.

Remedy has previously emphasized a long-tail sales strategy, and the more important point is what sits behind the headline figure. The game has entered profitability after recouping its development costs. It currently sells roughly 1 million copies per year, while the previous game in the series is still selling steadily. That is not an explosive performance, but it is a reliable one.

Whether Alan Wake 2 is worth buying depends on what the player wants from it. If you want something casual for a commute or a relaxing session before bed, its horror atmosphere may be too heavy, and the experience is rarely effortless. Players who enjoy cinematic storytelling, mystery-driven progression, and a cold, unsettling visual style are more likely to get something out of it, especially with enough uninterrupted time.

The next date to watch is September, when Control 2 is expected to launch. Analysts believe the release could send new players back toward Alan Wake 2. The logic is familiar: a new entry can push latecomers toward the earlier one, lifting interest in the older work as well.

For Remedy, that kind of overlap between its connected games may ultimately be more valuable than a single short-lived sales spike.